Improved long-term outcomes with IMRT: is it better technology or better physics?

Affiliations

Editorial

Michael J Zelefsky et al. Int J Radiat Oncol Biol Phys. 2013.

. 2013 Dec 1;87(5):867-8.

doi: 10.1016/j.ijrobp.2013.09.004.

¹ Department of Radiation Oncology, Memorial Sloan-Kettering Cancer Center, New York, New York. Electronic address: zelefskm@mskcc.org.

No abstract available

Comment on

Preliminary toxicity analysis of 3-dimensional conformal radiation therapy versus intensity modulated radiation therapy on the high-dose arm of the Radiation Therapy Oncology Group 0126 prostate cancer trial.
Michalski JM, Yan Y, Watkins-Bruner D, Bosch WR, Winter K, Galvin JM, Bahary JP, Morton GC, Parliament MB, Sandler HM. Michalski JM, et al. Int J Radiat Oncol Biol Phys. 2013 Dec 1;87(5):932-8. doi: 10.1016/j.ijrobp.2013.07.041. Epub 2013 Oct 8. Int J Radiat Oncol Biol Phys. 2013. PMID: 24113055 Free PMC article. Clinical Trial.

1. Zelefsky MJ, Fuks Z, Happersett L, et al. Clinical experience with intensity modulated radiation therapy (IMRT) in prostate cancer. Radiother Oncol. 2000;55:241–249. - PubMed
1. Alicikus ZA, Yamada Y, Zhang Z, et al. Ten-year outcomes of high-dose, intensity-modulated radiotherapy for localized prostate cancer. Cancer. 2011;117:1429–1437. - PubMed
1. Michalski JM, Yan Y, Watkins-Bruner D, et al. Preliminary toxicity analysis of 3-dimensional conformal radiation therapy versus intensity modulated radiation therapy on the high-dose arm of the Radiation Therapy Oncology Group 0126 prostate cancer trial. Int J Radiat Oncol Biol Phys. 2013;87:932–938. - PMC - PubMed
1. Zelefsky MJ, Kollmeier M, Cox B, et al. Improved clinical outcomes with high-dose image guided radiotherapy compared with non-IGRT for the treatment of clinically localized prostate cancer. Int J Radiat Oncol Biol Phys. 2012;84:125–129. - PubMed
1. Michalski JM, Gay H, Jackson A, et al. Radiation dose-volume effects in radiation-induced rectal injury. Int J Radiat Oncol Biol Phys. 2010;76:S123–S129. - PMC - PubMed